Francesca Lovat
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
97
Citations
6,939
Est. group size
~5
Recurring co-author estimate
Active years
34
Publishing since 1993
Francesca Lovat's research focuses on the molecular biology of cancer, particularly how small RNA molecules called microRNAs and proteins like Fra-2 control tumor growth, drug resistance, and disease progression in cancers such as pancreatic, lung, and bone cancer. The work also examines extracellular vesicles (small particles cells use to communicate) as potential tools for detecting cancer through blood tests (liquid biopsy). This research combines molecular genetics, cancer biology, and cell communication studies to understand and potentially improve cancer treatment responses.
Publication output was low and sporadic from 2017-2021, spiked sharply in 2023, and has since returned to a more modest, steady level through 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma
Proceedings of the National Academy of Sciences · 2026
- Exploring the Spatial Limits of Extracellular Vesicles‐Mediated Intercellular Communication
Journal of Extracellular Vesicles · 2025
- A Novel Mouse Model for Tissue-Specific Quantification of Circulating Extracellular Vesicles
The Journal of Liquid Biopsy · 2025
- Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma
Signal Transduction and Targeted Therapy · 2024
- Role of Fra-2 in cancer
Cell Death and Differentiation · 2023
- A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells
Oncogene · 2023
- Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance
Signal Transduction and Targeted Therapy · 2023
- Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state
Proceedings of the National Academy of Sciences · 2023
- Abstract 4823: The novel miR-15a/Fra-2/IGF1R axis drives response to starvation-induced cell stress in pancreatic ductal adenocarcinoma
Cancer Research · 2023
- Data from p27<sup>Kip1</sup> expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis
2023
- Supplementary Material from p27<sup>Kip1</sup> expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis
2023
- Data from p27<sup>Kip1</sup> expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis
2023
- Data from WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma
2023
- Supplementary Material from p27<sup>Kip1</sup> expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis
2023
- Supplementary Figures 1-7, Tables 1-6 from miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
2023
- Cancer Research×5
- Proceedings of the National Academy of Sciences×5
- Oncotarget×2
- Signal Transduction and Targeted Therapy×2
- Elsevier eBooks×2
- Carlo M. Croce
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Michela Garofalo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jing Peng
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jia Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Xinna Zhang
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile